Effect of Si-based agent on alcohol hangovers and liver damage caused by acute ethanol overdose.
Yoshihisa Koyama, Xin Ye, Yuki Kobayashi, Ikuei Hirota, Hikaru Kobayashi, Shoichi Shimada · Biochemistry and biophysics reports · 2025
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In fact, oral administration of the Si-based agent to mice has been shown to increase hydrogen concentration in the intestine. These preclinical findings add evidence about the molecular-hydrogen effects, outcomes, and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how hydrogen-supplemented jelly intake affected the outcomes measured in mice. In fact, oral administration of the Si-based agent to mice has been shown to increase hydrogen concentration in the intestine.
What the Researchers Studied
The researchers studied mice. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
2.3 Si powder ( 90 %) and converted into acetaldehyde via enzyme pathways such as alcohol dehydrogenase, cytochrome P450 2E1 (CYP2E1), and catalase [ 26 ]. as no adverse effects have been reported for the Si-based agent or molecular hydrogen [ 30 ], the Si-based agent has potential as an effective therapeutic strategy for alcohol hangovers and acute ethanol intoxication. In fact, oral administration of the Si-based agent to mice has been shown to increase hydrogen concentration in the intestine. The authors concluded that this study suggests that the Si-based agent has potential as an effective treatment for alcohol hangovers and alcohol-induced liver damage in the future.
Why These Findings Matter
This publication adds useful evidence about where molecular hydrogen did and did not change the measured outcomes, helping define the larger therapeutic evidence base.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was mice. The study used a preclinical animal experiment. The hydrogen delivery method was hydrogen-supplemented jelly intake.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.